Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Blood Dyscrasia Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07287228
What this trial is testing

The Safety and Efficacy of Daratumumab in Patients With Refractory Aplastic Anemia

Who this might be right for
Aplastic AnemiaRefractoryRelapse
Institute of Hematology & Blood Diseases Hospital, China 37
Early research (Phase 1)Study completedNCT03454165
What this trial is testing

BNC105P Combined With Ibrutinib

Who this might be right for
Chronic Lymphocytic Leukemia
Dartmouth-Hitchcock Medical Center 6
Testing effectiveness (Phase 2)Active Not RecruitingNCT04439357
What this trial is testing

Testing Trametinib as a Potential Targeted Treatment in Cancers With GNAQ or GNA11 Genetic Changes (MATCH-Subprotocol S2)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more
National Cancer Institute (NCI) 4
Post-approval studies (Phase 4)Study completedNCT03992001
What this trial is testing

Impact of the Preparation Method of Red Cell Concentrates on Transfusion Indices in Thalassemic Patients

Who this might be right for
Thalassemia Major
Università degli Studi di Ferrara 55
Post-approval studies (Phase 4)UnknownNCT00180128
What this trial is testing

AIDA2000 - Risk-Adapted Therapy for Patients With Acute Promyelocytic Leukemia

Who this might be right for
Leukemia, Promyelocytic, Acute
Technische Universität Dresden 80
Testing effectiveness (Phase 2)Study completedNCT01096992
What this trial is testing

Fludarabine, Bendamustine, and Rituximab (FBR) for Relapsed Chronic Lymphocytic Leukemia (CLL)

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 51
Not applicableLooking for participantsNCT07446777
What this trial is testing

FAST-M: Prolonged Overnight Fasting and Mediterranean Dietary Intervention for Patients With Multiple Myeloma or Its Precursor Disease

Who this might be right for
Multiple MyelomaMonoclonal Gammopathy of Undetermined SignificanceSmoldering Multiple Myeloma
University of Miami 120
Large-scale testing (Phase 3)Study completedNCT07267975
What this trial is testing

Effectiveness of Oral Iron Therapy in Iron Deficiency Anemia With Daily vs Alternate Day Dosing

Who this might be right for
Iron Deficiency AnemiaIron Deficiency Anemia Treatment
University of Child Health Sciences and Children's Hospital, Lahore 60
Testing effectiveness (Phase 2)Study completedNCT00062075
What this trial is testing

Romidepsin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)+5 more
National Cancer Institute (NCI) 47
Not applicableUnknownNCT04180657
What this trial is testing

Ghrelin Levels in Patients With Protein C Deficiency

Who this might be right for
Protein C Deficiency
University of Aarhus 60
Post-approval studies (Phase 4)Study completedNCT00413101
What this trial is testing

NeoRecormon (Epoetin Beta) in Patients With End Stage Renal Disease.

Who this might be right for
Anemia
Hoffmann-La Roche 50
Not applicableWithdrawnNCT00770419
What this trial is testing

Perceptions of Burden in Patients With Late-Stage Cancer and Their Caregivers

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersDepression+7 more
Rutgers, The State University of New Jersey
Testing effectiveness (Phase 2)Study completedNCT01217957
What this trial is testing

Ixazomib Administered in Combination With Lenalidomide and Low-Dose Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Millennium Pharmaceuticals, Inc. 65
Testing effectiveness (Phase 2)UnknownNCT03913312
What this trial is testing

Decitabine Combined With Unrelated Cord Blood Transplantation for Elderly Patients With AML

Who this might be right for
Acute Myeloid Leukemia
Ruijin Hospital 150
Testing effectiveness (Phase 2)Ended earlyNCT05317936
What this trial is testing

Pirtobrutinib (LOXO-305) Consolidation for MRD Eradication in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL) Treated With Venetoclax

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
M.D. Anderson Cancer Center 3
Early research (Phase 1)Study completedNCT00036257
What this trial is testing

Dose-Escalating and Safety Study of CP-461 in Patients With Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic Leukemia
Astellas Pharma Inc 15
Testing effectiveness (Phase 2)Study completedNCT02464657
What this trial is testing

Study of Idarubicin, Cytarabine, and Nivolumab in Patients With High-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)

Who this might be right for
LeukemiaAcute Myeloid LeukemiaMyelodysplastic Syndrome
M.D. Anderson Cancer Center 44
Early research (Phase 1)Ended earlyNCT01309412
What this trial is testing

CNTO 328 (Siltuximab) in Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Janssen Pharmaceutical K.K. 9
Testing effectiveness (Phase 2)Study completedNCT01590628
What this trial is testing

Allogeneic SCT of NiCord®, UCB-Derived Ex Vivo Expanded Stem and Progenitor Cells, in Patients With Hemoglobinopathies

Who this might be right for
Sickle Cell Disease & Thalassemia
Gamida Cell ltd 16
Testing effectiveness (Phase 2)Enrolling By InvitationNCT06253507
What this trial is testing

PCCLCHIM-p47 (Lentiviral Vector Transduced CD34 Plus Cells) in Patients With p47 Autosomal Recessive Chronic Granulomatous Disease (AR-CGD)

Who this might be right for
p47Autosomal RecessiveChronic Granulomatous Disease
National Institute of Allergy and Infectious Diseases (NIAID) 10
Next Page